封面
市场调查报告书
商品编码
1617043

医院感染控制市场报告:2030 年趋势、预测与竞争分析

Hospital-Acquired Infection Control Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

医院感染控制趋势与预测

全球医院感染控制市场的未来前景广阔,医院/ICU、门诊手术/诊断中心、疗养院/妇产中心市场充满机会。预计2024年至2030年全球医院感染控制市场将以1.7%的复合年增长率成长。该市场的主要驱动因素是人们对医院感染的认识和法规的不断提高以及抗生素抗药性病原体发生率的上升。

  • Lucintel 预测,防护屏障将在产品和服务类别中成长最快。
  • 在最终用途类别中,医院和重症监护室预计将成长最快。
  • 按地区划分,北美地区预计成长最快。

医院感染控制市场的策略性成长机会

医院感染控制市场在关键应用领域提供了多种策略成长机会。这些机会是由技术进步、对有效感染控制解决方案不断增长的需求以及不断变化的医疗保健需求所推动的。

  • 儿科感染控制解决方案:儿科患者对专门的感染控制解决方案的需求不断增长。满足医院环境中儿童独特需求的产品和实践的发展代表了医院感染管理市场的重大成长机会。
  • 先进灭菌设备:自动灭菌器、高效过滤器等先进灭菌设备的需求不断增加。这些技术提高了性能和可靠性,为感染控制领域的製造商和供应商创造了成长机会。
  • 整合数位健康解决方案:将电子健康记录(EHR) 和资料分析等数位健康解决方案整合到感染控制实践中可以增强监控和合规性。这种整合将带来更有效和简化的感染控制管理,并提供成长机会。
  • 开发具有成本效益的解决方案:具有成本效益的感染控制解决方案的市场正在不断增长,特别是在发展中地区。透过提供符合感染控制标准的经济实惠且高效的产品,我们能够推动新兴市场的成长并满足资源有限的医疗保健环境的需求。
  • 扩大感染控制服务:将感染控制服务委託给专业提供者的趋势日益明显。这为公司提供了一个机会,可以为希望加强感染预防策略的医疗机构提供全面的感染控制服务,包括审核、培训和管理。

这些成长机会透过推动创新、扩大产品范围和满足多样化的医疗保健需求,正在塑造 HAI 控制市场的未来。透过专注于开发专业解决方案、具成本效益的技术和综合服务,我们支持减少医院获得性感染和提高病人安全的总体目标。

医院感染控制市场的驱动因素与挑战

医院感染控制市场受到影响其成长和开发的各种驱动因素​​和挑战的影响。了解这些因素对于驾驭市场和反应不断变化的需求至关重要。

医院感染控制市场的驱动因素包括:

  • 技术进步:感染控制方面的技术进步,例如自动消毒系统和抗菌涂层,正在推动市场成长。这些创新将提高感染控制的有效性和效率,并支持减少医院感染的努力。
  • 提高感染控制意识:人们对感染控制和病人安全重要性的认识不断提高,推动了对先进感染控制解决方案的需求。医疗保健提供者正在投资技术和实践,以加强感染预防和改善患者治疗结果。
  • 收紧监管标准:收紧有关感染控制的监管标准和指南正在影响市场成长。医疗机构正在实施先进的技术和实践,以遵守这些法规并确保病人安全的高标准。
  • HAI 发生率不断增加:医院感染的增加增加了对有效感染控制解决方案的需求。医院正在寻求创新产品和实践来应对医院感染带来的挑战并降低感染率。
  • 医疗保健基础设施的成长:医疗保健基础设施的扩张和现代化,特别是在新兴市场,正在促进市场成长。改进的设施和先进的感染控制技术的使用正在支持有效感染控制措施的发展。

医院感染控制市场面临的挑战如下:

  • 先进技术的高成本:与先进感染控制技术相关的高成本可能成为采用的障碍,特别是在资源有限的环境中。解决负担能力和成本效益对于广泛采用这些解决方案至关重要。
  • 合规和培训问题:确保遵守感染控制通讯协定并为医务人员提供适当的培训是一项挑战。遵守最佳实践的变化可能会影响感染控制的有效性和患者的安全。
  • 监管和安全问题:了解感染控制产品的复杂监管要求并解决安全问题是一项挑战。确保产品符合监管标准并解决潜在风险对于维持市场可接受性至关重要。

目录

第一章执行摘要

第二章全球医院感染控制市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球医院感染控制市场趋势(2018-2023)与预测(2024-2030)
  • 全球医院感染控制市场:依产品/服务分类
    • 防护屏障
    • 消毒
    • 消毒剂
    • 消毒器
    • 内视镜再生产品
    • 其他的
  • 全球医院感染控制市场:依最终用途分类
    • 医院及重症监护室
    • 门诊手术/诊断中心
    • 疗养院/产科中心

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的医院感染控制市场
  • 北美医院感染控制市场
  • 欧洲医院感染控制市场
  • 亚太医院感染控制市场
  • 其他地区医院感染控制市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球医院感染控制市场成长机会(按产品和服务划分)
    • 全球医院感染控制市场成长机会(依最终用途)
    • 按地区分類的全球医院感染控制市场成长机会
  • 全球医院感染控制市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球医院感染控制市场的能力
    • 全球医院感染控制市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Steris
  • Sotera Health
  • Getinge
  • Advanced Sterilization Products
  • Ecolab
  • 3M
  • Matachana
  • MMM
  • Belimed
  • Reckitt Benckiser
简介目录

Hospital-Acquired Infection Control Trends and Forecast

The future of the global hospital-acquired infection control market looks promising with opportunities in the hospital & ICU, ambulatory surgical & diagnostic center, and nursing home & maternity center markets. The global hospital-acquired infection control market is expected to grow with a CAGR of 1.7% from 2024 to 2030. The major drivers for this market are the increasing awareness and regulations regarding hospital-acquired infections and the rising incidence of antibiotic-resistant pathogens.

  • Lucintel forecasts that, within the product & service category, the protective barrier is expected to witness the highest growth.
  • Within the end-use category, hospital & ICU is expected to witness the highest growth.
  • In terms of regions, North America is expected to witness the highest growth.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Hospital-Acquired Infection Control Market

The hospital-acquired infection control market is evolving with several emerging trends driven by technological advancements, increased focus on patient safety, and changing regulatory landscapes.

  • Integration of Real-Time Monitoring Systems: Real-time monitoring systems are becoming increasingly important for tracking infection control compliance and identifying potential risks. These systems use data analytics to monitor hygiene practices and provide alerts, helping healthcare facilities promptly address infection control issues and improve patient safety.
  • Advancements in Antimicrobial Coatings: The development of advanced antimicrobial coatings for surfaces and medical devices is a key trend. These coatings inhibit the growth of pathogens and reduce the risk of HAIs. The use of such coatings enhances the effectiveness of infection control measures in healthcare settings.
  • Increased Adoption of Automated Disinfection Technologies: Automated disinfection technologies, such as UV-C light and robotic systems, are gaining traction. These technologies provide efficient and consistent disinfection, reducing reliance on manual cleaning processes. They contribute to improved infection control by ensuring high levels of cleanliness in hospital environments.
  • Focus on Infection Prevention Training: There is a growing emphasis on comprehensive infection prevention training for healthcare staff. Training programs are being developed to enhance knowledge of infection control protocols and improve adherence to best practices. This trend aims to reduce human errors and enhance overall infection control efforts.
  • Regulatory and Compliance Initiatives: Enhanced regulatory and compliance initiatives are shaping the HAI control market. Stricter guidelines and standards for infection control practices are being enforced by healthcare authorities. Compliance with these regulations is driving the adoption of advanced infection control technologies and practices.

These trends are reshaping the HAI control market by driving innovation, improving infection prevention measures, and enhancing overall patient safety. The integration of new technologies and a stronger focus on training and compliance contribute to more effective infection control strategies in healthcare settings.

Recent Developments in the Hospital-Acquired Infection Control Market

The hospital-acquired infection control market is experiencing several key developments, reflecting advancements in technology, changes in regulations, and evolving healthcare needs.

  • Development of Advanced Disinfection Technologies: New disinfection technologies, such as automated UV-C disinfection systems and electrostatic sprayers, are being introduced. These technologies offer more effective and efficient disinfection processes, improving hospital hygiene and reducing the risk of HAIs.
  • Expansion of Antimicrobial Surface Coatings: The use of antimicrobial coatings on high-touch surfaces and medical equipment is increasing. These coatings help inhibit microbial growth and reduce the transmission of infections, contributing to improved infection control in healthcare settings.
  • Implementation of Real-Time Monitoring Systems: Real-time monitoring systems are being adopted to track and analyze infection control practices. These systems provide valuable data and alerts, helping hospitals address potential issues promptly and ensure compliance with infection control protocols.
  • Enhanced Focus on Infection Prevention Education: There is a growing emphasis on training and education programs for healthcare professionals. These programs aim to improve knowledge and adherence to infection control practices, reducing the incidence of HAIs and promoting a culture of safety.
  • Strengthening Regulatory Compliance: Regulatory bodies are enforcing stricter infection control standards and guidelines. Hospitals are responding by adopting advanced infection control technologies and practices to meet these requirements and ensure patient safety.

These developments are enhancing the effectiveness of infection control measures, driving technological innovation, and improving compliance with regulations. They contribute to a safer healthcare environment by reducing the incidence of hospital-acquired infections and promoting better patient outcomes.

Strategic Growth Opportunities for Hospital-Acquired Infection Control Market

The hospital-acquired infection control market offers several strategic growth opportunities across key applications. These opportunities are driven by technological advancements, increasing demand for effective infection control solutions, and evolving healthcare needs.

  • Pediatric Infection Control Solutions: There is a growing need for specialized infection control solutions tailored for pediatric patients. Developing products and practices that address the unique needs of children in hospital settings presents a significant growth opportunity in the HAI control market.
  • Advanced Sterilization Equipment: The demand for advanced sterilization equipment, such as automated sterilizers and high-efficiency filters, is increasing. These technologies offer improved performance and reliability, presenting growth opportunities for manufacturers and suppliers in the infection control sector.
  • Integration of Digital Health Solutions: Integrating digital health solutions, such as electronic health records (EHR) and data analytics, with infection control practices can enhance monitoring and compliance. This integration offers opportunities for growth by providing more effective and streamlined infection control management.
  • Development of Cost-Effective Solutions: The market for cost-effective infection control solutions is expanding, particularly in developing regions. Offering affordable and efficient products that meet infection control standards can drive growth in emerging markets and address the needs of resource-limited healthcare settings.
  • Expansion of Infection Control Services: There is a growing trend toward outsourcing infection control services to specialized providers. This presents opportunities for companies to offer comprehensive infection control services, including audits, training, and management, to healthcare facilities seeking to enhance their infection prevention strategies.

These growth opportunities are shaping the future of the HAI control market by driving innovation, expanding product offerings, and addressing diverse healthcare needs. Focused development in specialized solutions, cost-effective technologies, and integrated services supports the overall goal of reducing hospital-acquired infections and improving patient safety.

Hospital-Acquired Infection Control Market Driver and Challenges

The hospital-acquired infection control market is influenced by a range of drivers and challenges that impact its growth and development. Understanding these factors is essential for navigating the market and addressing evolving needs.

The factors responsible for driving the hospital-acquired infection control market include:

  • Technological Advancements: Technological advancements in infection control, such as automated disinfection systems and antimicrobial coatings, are driving market growth. These innovations improve the effectiveness and efficiency of infection control measures, supporting efforts to reduce HAIs.
  • Increasing Awareness of Infection Control: Growing awareness about the importance of infection control and patient safety is driving demand for advanced infection control solutions. Healthcare providers are investing in technologies and practices to enhance infection prevention and improve patient outcomes.
  • Stricter Regulatory Standards: Enhanced regulatory standards and guidelines for infection control are influencing market growth. Healthcare facilities are adopting advanced technologies and practices to comply with these regulations and ensure high standards of patient safety.
  • Rising Incidence of HAIs: The increasing incidence of hospital-acquired infections is driving the demand for effective infection control solutions. Hospitals are seeking innovative products and practices to address the challenges posed by HAIs and reduce infection rates.
  • Growth in Healthcare Infrastructure: Expansion and modernization of healthcare infrastructure, particularly in emerging markets, are contributing to market growth. Improved facilities and access to advanced infection control technologies support the development of effective infection control measures.

Challenges in the hospital-acquired infection control market are:

  • High Costs of Advanced Technologies: The high costs associated with advanced infection control technologies can be a barrier to adoption, particularly in resource-limited settings. Addressing affordability and cost-effectiveness is crucial for the broader implementation of these solutions.
  • Compliance and Training Issues: Ensuring compliance with infection control protocols and providing adequate training for healthcare staff can be challenging. Variability in adherence to best practices can impact the effectiveness of infection control measures and patient safety.
  • Regulatory and Safety Concerns: Navigating complex regulatory requirements and addressing safety concerns related to infection control products can pose challenges. Ensuring that products meet regulatory standards and address potential risks is essential for maintaining market acceptance.

The drivers and challenges in the hospital-acquired infection control market shape its growth and development. Technological advancements, increasing awareness, and regulatory standards drive market expansion, while high costs, compliance issues, and regulatory concerns pose challenges. Addressing these factors is crucial for advancing infection control practices and improving patient safety in healthcare settings.

List of Hospital-Acquired Infection Control Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies hospital-acquired infection control companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hospital-acquired infection control companies profiled in this report include-

  • Steris
  • Sotera Health
  • Getinge
  • Advanced Sterilization Products
  • Ecolab
  • 3M
  • Matachana
  • MMM
  • Belimed
  • Reckitt Benckiser

Hospital-Acquired Infection Control by Segment

The study includes a forecast for the global hospital-acquired infection control by product & service, end use, and region.

Hospital-Acquired Infection Control Market by Product & Service [Analysis by Value from 2018 to 2030]:

  • Protective Barrier
  • Sterilization
  • Disinfectant
  • Disinfector
  • Endoscope Reprocessing Product
  • Others

Hospital-Acquired Infection Control Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospital & ICU
  • Ambulatory Surgical & Diagnostic Center
  • Nursing Home & Maternity Center

Hospital-Acquired Infection Control Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Hospital-Acquired Infection Control Market

The hospital-acquired infection (HAI) control market is advancing rapidly as healthcare systems worldwide focus on reducing infection rates and improving patient safety. Innovations in infection control technologies, increased awareness, and regulatory pressures are driving these developments. Key markets, including the United States, China, Germany, India, and Japan, are witnessing significant changes in infection control practices and technologies aimed at combating HAIs.

  • United States: In the U.S., there is a notable shift toward advanced infection control technologies, including real-time monitoring systems and enhanced sterilization methods. The implementation of stringent infection prevention protocols and increased use of antimicrobial surfaces are key trends. Regulatory mandates and heightened awareness around HAIs are further driving the adoption of comprehensive infection control strategies across healthcare facilities.
  • China: China is experiencing growth in the HAI control market due to increased investment in healthcare infrastructure and infection prevention technologies. The country is focusing on improving hospital hygiene practices and implementing more rigorous infection control measures. Government initiatives and growing public health awareness are contributing to the expansion of advanced infection control solutions in hospitals.
  • Germany: Germany is seeing advancements in infection control practices with the adoption of automated disinfection systems and improved personal protective equipment (PPE). The focus is on integrating new technologies with traditional infection control methods to enhance efficacy. Additionally, Germany is emphasizing the importance of staff training and adherence to infection prevention protocols to reduce HAIs.
  • India: In India, the HAI control market is expanding as hospitals adopt new infection control technologies and practices. The emphasis is on cost-effective solutions and improving hospital hygiene standards. Government initiatives aimed at reducing infection rates and increasing awareness about HAIs are driving growth in the infection control market.
  • Japan: Japan is witnessing advancements in infection control technologies, including the use of advanced sterilization techniques and antimicrobial coatings. There is a strong focus on integrating technology with traditional infection control measures to enhance overall effectiveness. Japan's emphasis on patient safety and regulatory compliance is contributing to the growth of the HAI control market.

Features of the Global Hospital-Acquired Infection Control Market

Market Size Estimates: Hospital-acquired infection control market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hospital-acquired infection control market size by product & service, end use, and region in terms of value ($B).

Regional Analysis: Hospital-acquired infection control market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, end uses, and regions for the hospital-acquired infection control market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hospital-acquired infection control market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hospital-acquired infection control market by product & service (protective barrier, sterilization, disinfectant, disinfector, endoscope reprocessing product, and others), end use (hospital & ICU, ambulatory surgical & diagnostic center, and nursing home & maternity center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hospital-Acquired Infection Control Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hospital-Acquired Infection Control Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hospital-Acquired Infection Control Market by Product & Service
    • 3.3.1: Protective Barrier
    • 3.3.2: Sterilization
    • 3.3.3: Disinfectant
    • 3.3.4: Disinfector
    • 3.3.5: Endoscope Reprocessing Product
    • 3.3.6: Others
  • 3.4: Global Hospital-Acquired Infection Control Market by End Use
    • 3.4.1: Hospital & ICU
    • 3.4.2: Ambulatory Surgical & Diagnostic Center
    • 3.4.3: Nursing Home & Maternity Center

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hospital-Acquired Infection Control Market by Region
  • 4.2: North American Hospital-Acquired Infection Control Market
    • 4.2.1: North American Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.2.2: North American Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center
  • 4.3: European Hospital-Acquired Infection Control Market
    • 4.3.1: European Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.3.2: European Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center
  • 4.4: APAC Hospital-Acquired Infection Control Market
    • 4.4.1: APAC Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.4.2: APAC Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center
  • 4.5: ROW Hospital-Acquired Infection Control Market
    • 4.5.1: ROW Market by Product & Service: Protective Barrier, Sterilization, Disinfectant, Disinfector, Endoscope Reprocessing Product, and Others
    • 4.5.2: ROW Market by End Use: Hospital & ICU, Ambulatory Surgical & Diagnostic Center, and Nursing Home & Maternity Center

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hospital-Acquired Infection Control Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Hospital-Acquired Infection Control Market by End Use
    • 6.1.3: Growth Opportunities for the Global Hospital-Acquired Infection Control Market by Region
  • 6.2: Emerging Trends in the Global Hospital-Acquired Infection Control Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hospital-Acquired Infection Control Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hospital-Acquired Infection Control Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Steris
  • 7.2: Sotera Health
  • 7.3: Getinge
  • 7.4: Advanced Sterilization Products
  • 7.5: Ecolab
  • 7.6: 3M
  • 7.7: Matachana
  • 7.8: MMM
  • 7.9: Belimed
  • 7.10: Reckitt Benckiser